Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006).
Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006).
复制标题
DOI:
10.1289/ehp.1307234
复制
发表时间:
2014-03
影响因子:
10.4
通讯作者:
Buser MC
中科院分区:
文献类型:
--
作者:
Scinicariello F;Buser MC
Background: Polycyclic aromatic hydrocarbons (PAHs) are known carcinogens and suspected endocrine disruptors. Prenatal exposure to PAHs has been associated with obesity in early childhood. Objective: We examined the association of urinary PAH metabolites with adiposity outcomes [body mass index (BMI) z-score, waist circumference (WC), and rate of obesity] in children and adolescents. Methods: We performed whole-sample analyses of 3,189 individuals 6–19 years of age who participated in the 2001–2006 National Health and Nutrition Examination Survey. We performed multivariate linear and logistic regression to analyze the association of BMI z-score, WC, and obesity with concentrations of single urinary PAH compounds and the sum of PAHs. Furthermore, the analyses were stratified by developmental stage [i.e., children (6–11 years) and adolescents (12–19 years)]. Results: BMI z-score, WC, and obesity were positively associated with the molecular mass sum of the PAHs and the total sum of naphthalene metabolites. Most associations increased monotonically with increasing quartiles of exposure among children 6–11 years of age, whereas dose–response trends were less consistent for adolescents (12–19 years of age). Neither total PAHs nor total naphthalene metabolites were associated with overweight in either age group, and there was little evidence of associations between the outcomes and individual PAHs. Conclusions: Total urinary PAH metabolites and naphthalene metabolites were associated with higher BMI, WC, and obesity in children 6–11 years of age, with positive but less consistent associations among adolescents. Citation: Scinicariello F, Buser MC. 2014. Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001–2006). Environ Health Perspect 122:299–303; http://dx.doi.org/10.1289/ehp.1307234
登录
查看更多内容
影响因子:
10.4
作者:
Choi H;Rauh V;Garfinkel R;Tu Y;Perera FP
通讯作者:
Perera FP
影响因子:
4.1
作者:
Rubin BS;Soto AM
通讯作者:
Soto AM
影响因子:
3.5
作者:
Lu C;Cheng SY
通讯作者:
Cheng SY
影响因子:
4.8
作者:
Grun, Felix;Blumberg, Bruce
通讯作者:
Blumberg, Bruce
DOI:
10.1016/0022-4731(87)90303-7
发表时间:
1987-01-01
影响因子:
4.1
作者:
CHANG, CS;LIAO, ST
通讯作者:
LIAO, ST